By Kris Gustafson, Vice President, Global Head Patient Centered Technologies
The healthcare industry has been working around-the-clock to swiftly respond to the COVID-19 pandemic. It has become clear that the most essential weapon against COVID-19 – and getting things back to ‘normal’ – will be a safe and effective vaccine.
It usually takes years to develop and test new vaccine candidates. However, recent advances in scientific research, data collection, and analytics tools are making it possible for developers to shear months off this process without compromising the integrity of the study and data. These tools include the use of electronic Clinical Outcomes Assessments (eCOAs), which can be rapidly implemented to capture patient reported outcomes (PROs), giving sponsors almost instant access to study trends.